Original language | English |
---|---|
Pages (from-to) | 2826 - 2833 |
Number of pages | 8 |
Journal | Leukemia and Lymphoma |
Volume | 56 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2015 |
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
Thomas J Kipps, Herbert Aaron Eradat, Sebastian Grosicki, John Catalano, Walter Cosolo, Iryna S Dyagil, Sreeni Yalamanchili, Akiko Chai, Srikumar Sahasranaman, Elizabeth A Punnoose, Deborah Hurst, Halyna Pylypenko
Research output: Contribution to journal › Article › Research › peer-review
154
Citations
(Scopus)